Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone LAI for Methamphetamine Dependence
NCT00284206Phase 2Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Jan 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risperidone in methamphetamine use disorder (MUD), sponsored by Seattle Institute for Biomedical and Clinical Research. Started Jan 2006; status: completed.
02
Drugs
risperidone
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00284206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284206.